Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Authors: May M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM, Ferrucci L
Date: 2007
Scope of interest: endocrinology, physiology
Authors: D’Amico C. et al.
Date: 2022
Scope of interest: Transfusion Medicine
Authors: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G
Date: 2015
Scope of interest: metabolism, diabetes
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide